Literature DB >> 6994637

Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.

K B Crossley, J C Rotschafer, M M Chern, K E Mead, D E Zaske.   

Abstract

A newly developed radioimmunoassay was used to measure the concentration of vancomycin in 137 specimens of serum from patients being treated with this antibiotic. Of these sera, 84 were also analyzed with a microbiological assay technique for vancomycin. Duplicate determinations were done with each of the techniques. Individual values and averaged values for both methods were used for statistical analyses. The correlation coefficients between all possible combinations of radioimmunoassay and microbiological assay results for the 84 sera were greater than or equal to 0.99 (P less than 0.01). Values for the regression coefficients of radioimmunoassay results on microbiological assay results ranged from 0.98 +/- 0.01 to 1.03 +/- 0.01. The mean percent deviation of radioimmunoassay versus microbiological assay results was -1.56 +/- 0.60. A one-way analysis of variance demonstrated that the use of different standard curves for each batch of specimens assayed by microbiological assay did not significantly influence the results (P = 0.07). The microbiological assay and the radioimmunoassay for measurement of serum vancomycin levels yielded essentially identical results.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994637      PMCID: PMC283847          DOI: 10.1128/AAC.17.4.654

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital.

Authors:  J J Klimek; F J Marsik; R C Bartlett; B Weir; P Shea; R Quintiliani
Journal:  Am J Med       Date:  1976-09       Impact factor: 4.965

2.  Radioimmunoassay of iodinated tobramycin.

Authors:  A Broughton; J E Strong; L K Pickering; G P Bodney
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

3.  Epidemiologic investigation of methicillin resistant Staphylococcus aureus in a burn unit.

Authors:  E D Everett; T R McNitt; A E Rahm; D L Stevens; H E Peterson
Journal:  Mil Med       Date:  1978-03       Impact factor: 1.437

4.  Vancomycin. A second look.

Authors:  A L Esposito; R A Gleckman
Journal:  JAMA       Date:  1977-10-17       Impact factor: 56.272

5.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09

6.  An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies.

Authors:  K Crossley; D Loesch; B Landesman; K Mead; M Chern; R Strate
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

Review 7.  Vancomycin revisited.

Authors:  F V Cook; W E Farrar
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

8.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

  9 in total
  7 in total

1.  Determination of vancomycin in human serum by high-pressure liquid chromatography.

Authors:  F Jehl; C Gallion; R C Thierry; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

2.  Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum.

Authors:  B H Ackerman; H G Berg; R G Strate; J C Rotschafer
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

3.  Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.

Authors:  M A Pfaller; D J Krogstad; G G Granich; P R Murray
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations.

Authors:  J C Rotschafer; K Crossley; D E Zaske; K Mead; R J Sawchuk; L D Solem
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Sensitive radioimmunoassay for vancomycin.

Authors:  K L Fong; D H Ho; L Bogerd; T Pan; N S Brown; L Gentry; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

7.  Comparison of vancomycin disposition in rats with normal and abnormal renal functions.

Authors:  M S Engineer; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.